Search

everythinglearnresearchcommunity

for

Search:↓

NB-002 is a promising new topical treatment for fungal nail infections, showing better results than a non-medicated option.

ODC overexpression in hair cells increases tumor growth by reducing Notch signaling.

Patients with Focal Dermal Hypoplasia often experience skin, nail, hair, and bone issues, and may benefit from calcium and vitamin D supplements.

Most patients with frontal fibrosing alopecia are postmenopausal women, and treatments like finasteride and dutasteride can improve or stabilize the condition.

Chronic GnRHa treatment can help manage endometrial hyperplasia and reduce ovarian androgen excess in PCO patients.

A new nanoemulsion increases oxygen for hair cells, leading to better hair growth.

FOL-005, a new substance, was found to reduce hair growth without toxicity when injected into skin, suggesting it could be used to treat excessive hair growth.

NBCCS and BFHS might be the same syndrome, helping better identify and manage cases.

Frontal fibrosing alopecia is a poorly understood condition with increasing cases and unclear treatment effectiveness.

RORA may help regulate hair growth by affecting hair follicle stem cells.

Combining CAF regimen with fufangbanmao capsules improves thyroid cancer treatment outcomes and reduces side effects.

Frontal fibrosing alopecia may be caused by an autoimmune reaction and hormonal imbalance.

Sorafenib may cause hand-foot and stump syndrome, requiring early detection and management.

Hair follicles can regenerate after radiation damage but not during a specific growth phase.

5-α-reductase inhibitors, intralesional steroids, and hydroxychloroquine are the most effective treatments for frontal fibrosing alopecia.

Alopecia areata patients have higher osteopontin levels and more eye changes, but their vision remains unaffected.

The review suggests more research is needed to understand Frontal fibrosing alopecia, a condition causing hairline recession in postmenopausal women.

Fusaric acid may help control Orobanche ramosa by activating plant defenses.

Frontal fibrosing alopecia can cause sudden hair loss on limbs, similar to scalp hair loss.

FPHL is a common, age-related, genetic hair loss with unclear causes and limited treatment options.

Ornithine decarboxylase is crucial for human hair growth and the hair cycle.

Two siblings had a rare immune disorder caused by a FOXN1 gene mutation.

OMICS International aimed to make scientific research freely accessible to everyone.

Oral difelikefalin significantly reduces itch in notalgia paresthetica.

Targeting ornithine decarboxylase can help prevent skin cancer.

A girl with a rare genetic disorder had a unique bone condition, highlighting the need for careful diagnosis and suggesting the disorder might be more common than thought.

MOF controls skin development by regulating genes for mitochondria and cilia.

Frontal fibrosing alopecia has occurred in two related male families.

Hydrogel-based hair follicle organoids could help treat hair loss and improve drug testing.

HOXC13 is essential for hair and nail development by regulating Foxn1.